KeyBanc raised the firm’s price target on Emerson (EMR) to $150 from $125 and keeps an Overweight rating on the shares following an eventful Q1 earnings season and the firm’s recent Industrials and Basic Materials Conference in Boston. While broader macro uncertainty remains elevated amid highly fluid global trade dynamics, KeyBanc thinks recent data points relative to its coverage have been better than feared.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue